BCWORLD PHARM. Co., Ltd. (200780.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	80.3B	75.8B	74.8B	75.1B	72.7B
Cost of Revenue	51.7B	48.7B	46.8B	43.2B	48.5B
Gross Profit	28.7B	27.1B	28.0B	31.9B	24.2B
Operating Expenses
R&D Expense	8.3B	6.3B	7.8B	6.1B	770.7M
SG&A Expense	9.3B	7.0B	6.5B	8.6B	10.2B
General & Admin Expense	2.2B	2.9B	3.3B	5.0B	6.8B
Selling & Marketing Expense	2.8B	4.1B	3.2B	3.6B	3.4B
Other Expenses	10.5B	11.7B	12.3B	10.9B	11.3B
Total Operating Expenses	25.9B	25.1B	26.5B	25.6B	22.3B
Cost and Expenses	77.5B	73.5B	73.3B	68.7B	70.8B
Operating Income (EBIT)	2.8B	2.0B	1.5B	6.4B	1.9B
Non-Operating
Interest Income	97.6M	122.2M	207.9M	179.8M	63.5M
Interest Expense	4.1B	4.2B	4.8B	5.2B	3.8B
Net Interest Income	(4.0B)	(4.1B)	(4.6B)	(5.1B)	(3.7B)
Other Non-Op Income/Expense	(3.6B)	(4.2B)	(4.3B)	(5.2B)	(3.4B)
Non-Operating Income (excl Interest)	(739.4M)	—	(494.3M)	(75.0M)	(407.0M)
EBT (Pre-Tax Income)	(777.5M)	(2.2B)	(2.8B)	1.2B	(1.5B)
Income Tax Expense	486.6M	931.4M	550.1M	(1.7B)	(1.6B)
Bottom Line
Net Income	(2.9B)	(4.9B)	(4.4B)	2.6B	281.3M
Earnings from Cont. Ops	(1.3B)	(3.1B)	(3.3B)	2.9B	59.8M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(2.9B)	(4.9B)	(4.4B)	2.6B	281.3M
Per Share
Basic EPS	(₩304)	(₩527)	(₩477)	₩258	₩27
Diluted EPS	(₩623)	(₩527)	(₩477)	₩258	₩27
Revenue Per Share	₩7,859	₩7,077	₩8,060	₩8,900	₩8,531
Shares
Basic Shares Outstanding	10.2M	10.7M	9.3M	8.4M	8.5M
Diluted Shares Outstanding	10.2M	10.7M	9.3M	8.4M	8.5M
Profitability Metrics
EBITDA	11.0B	9.9B	9.7B	13.9B	9.5B
D&A	8.2B	7.9B	7.7B	7.5B	7.3B
EBIT	2.8B	2.0B	2.0B	6.4B	2.3B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026